PHILADELPHIA — (Feb. 28, 2024) — The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells…
PHILADELPHIA — (February 28, 2025) —The Wistar Institute welcomes its newest faculty member, Colby Maldini, Ph.D., who joins Wistar’s HIV Cure and Viral Diseases Center as a Caspar Wistar Fellow…
PHILADELPHIA — (February 17th, 2025) — Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target a…
PHILADELPHIA — (February 5, 2025) —The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. The…
PHILADELPHIA — (January 30, 2025) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center is expanding its signature apprenticeship programs and bolstering job opportunities in…
In newly reported clinical trial results, The Wistar Institute and Stanford University have successfully tested an investigational drug for the treatment of Epstein-Barr Virus (EBV)-positive nasophar…
PHILADELPHIA — (December 20th, 2024) — In its annual Excellence Index, Newsweek and the Best Practice Institute has recognized The Wistar Institute as one of the world’s top 1000 companies. Wistar le…
PHILADELPHIA — (December 10, 2024) — The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next t…
PHILADELPHIA — (December 3rd, 2024) — The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distingu…
PHILADELPHIA — (Nov. 27, 2024) — Governor Josh Shapiro’s Administration, through the Commonwealth of Pennsylvania Redevelopment Assistance Capital Program (RACP), has granted The Wistar Institute $2…
